pharma majors

Lupin to beef up branded portfolio through alliances

"In 2015-16, the company remains committed to continuing to strengthen its branded portfolio with the launch of additional products by not only creating alliances but also developing its own pipeline and making strategic brand acquisitions in US markets," Lupin said in its annual report here.

Jun 28, 2015, 15:51 PM IST

High Court stays Rs 1.35 cr demand slapped on Novartis by NPPA

Novartis, in its plea, claimed that the government by a June 14, 2013 notification had revised the price of its drug, Regestrone, used for regulating women's menstrual cycle.

Jun 01, 2015, 17:15 PM IST